DENTSPLY SIRONA Inc. (XRAY)
USD 12.66
(-4.38%)
USD 12.66
(-4.38%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.96 Billion USD | 1.1% |
| 2022 | 3.92 Billion USD | -7.74% |
| 2021 | 4.25 Billion USD | 27.2% |
| 2020 | 3.34 Billion USD | -17.06% |
| 2019 | 4.02 Billion USD | 1.08% |
| 2018 | 3.98 Billion USD | -0.18% |
| 2017 | 3.99 Billion USD | 6.62% |
| 2016 | 3.74 Billion USD | 40.05% |
| 2015 | 2.67 Billion USD | -8.5% |
| 2014 | 2.92 Billion USD | -0.95% |
| 2013 | 2.95 Billion USD | 0.76% |
| 2012 | 2.92 Billion USD | 15.4% |
| 2011 | 2.53 Billion USD | 14.26% |
| 2010 | 2.22 Billion USD | 2.83% |
| 2009 | 2.15 Billion USD | -1.54% |
| 2008 | 2.19 Billion USD | 9.15% |
| 2007 | 2 Billion USD | 11.01% |
| 2006 | 1.81 Billion USD | 5.56% |
| 2005 | 1.71 Billion USD | 1.23% |
| 2004 | 1.69 Billion USD | 7.85% |
| 2003 | 1.57 Billion USD | 3.78% |
| 2002 | 1.51 Billion USD | 34.07% |
| 2001 | 1.12 Billion USD | 26.89% |
| 2000 | 889.79 Million USD | 7.09% |
| 1999 | 830.9 Million USD | 4.5% |
| 1998 | 795.1 Million USD | 10.31% |
| 1997 | 720.8 Million USD | 9.78% |
| 1996 | 656.6 Million USD | 14.79% |
| 1995 | 572 Million USD | 8.99% |
| 1994 | 524.8 Million USD | -5.03% |
| 1993 | 552.6 Million USD | 553.19% |
| 1992 | 84.6 Million USD | 55.23% |
| 1991 | 54.5 Million USD | 85.37% |
| 1990 | 29.4 Million USD | 58.06% |
| 1989 | 18.6 Million USD | 14.81% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 984 Million USD | 3.25% |
| 2024 Q1 | 953 Million USD | -5.83% |
| 2023 Q4 | 1.01 Billion USD | 6.86% |
| 2023 Q1 | 978 Million USD | -0.51% |
| 2023 FY | 3.96 Billion USD | 1.1% |
| 2023 Q3 | 947 Million USD | -7.88% |
| 2023 Q2 | 1.02 Billion USD | 5.11% |
| 2022 Q4 | 983 Million USD | 3.8% |
| 2022 Q3 | 947 Million USD | -7.43% |
| 2022 Q2 | 1.02 Billion USD | 6.01% |
| 2022 Q1 | 965 Million USD | -11.31% |
| 2022 FY | 3.92 Billion USD | -7.74% |
| 2021 Q2 | 1.06 Billion USD | 3.89% |
| 2021 FY | 4.25 Billion USD | 27.2% |
| 2021 Q4 | 1.08 Billion USD | 1.78% |
| 2021 Q1 | 1.02 Billion USD | -5.08% |
| 2021 Q3 | 1.06 Billion USD | 0.19% |
| 2020 Q3 | 894.8 Million USD | 82.39% |
| 2020 FY | 3.34 Billion USD | -17.06% |
| 2020 Q1 | 874.3 Million USD | -21.34% |
| 2020 Q4 | 1.08 Billion USD | 20.92% |
| 2020 Q2 | 490.6 Million USD | -43.89% |
| 2019 FY | 4.02 Billion USD | 1.08% |
| 2019 Q2 | 1 Billion USD | 6.68% |
| 2019 Q4 | 1.11 Billion USD | 15.53% |
| 2019 Q3 | 962.1 Million USD | -4.69% |
| 2019 Q1 | 946.2 Million USD | -10.71% |
| 2018 Q1 | 956.1 Million USD | -12.36% |
| 2018 Q4 | 1.05 Billion USD | 14.14% |
| 2018 Q3 | 928.4 Million USD | -10.91% |
| 2018 FY | 3.98 Billion USD | -0.18% |
| 2018 Q2 | 1.04 Billion USD | 8.99% |
| 2017 Q4 | 1.09 Billion USD | 8.11% |
| 2017 FY | 3.99 Billion USD | 6.62% |
| 2017 Q3 | 1 Billion USD | 1.66% |
| 2017 Q2 | 992.7 Million USD | 10.24% |
| 2017 Q1 | 900.5 Million USD | -9.63% |
| 2016 FY | 3.74 Billion USD | 40.05% |
| 2016 Q1 | 772.6 Million USD | 15.12% |
| 2016 Q4 | 996.5 Million USD | 4.43% |
| 2016 Q3 | 954.2 Million USD | -6.63% |
| 2016 Q2 | 1.02 Billion USD | 32.28% |
| 2015 FY | 2.67 Billion USD | -8.5% |
| 2015 Q3 | 648.9 Million USD | -7.04% |
| 2015 Q4 | 671.1 Million USD | 3.42% |
| 2015 Q2 | 698 Million USD | 6.35% |
| 2015 Q1 | 656.32 Million USD | -8.72% |
| 2014 Q3 | 708.24 Million USD | -7.45% |
| 2014 Q1 | 730.11 Million USD | -3.12% |
| 2014 FY | 2.92 Billion USD | -0.95% |
| 2014 Q4 | 719.04 Million USD | 1.53% |
| 2014 Q2 | 765.22 Million USD | 4.81% |
| 2013 Q1 | 732.08 Million USD | -2.81% |
| 2013 Q2 | 761.01 Million USD | 3.95% |
| 2013 Q3 | 704.01 Million USD | -7.49% |
| 2013 Q4 | 753.65 Million USD | 7.05% |
| 2013 FY | 2.95 Billion USD | 0.76% |
| 2012 Q1 | 716.41 Million USD | -2.93% |
| 2012 Q2 | 762.99 Million USD | 6.5% |
| 2012 Q3 | 695.73 Million USD | -8.82% |
| 2012 Q4 | 753.28 Million USD | 8.27% |
| 2012 FY | 2.92 Billion USD | 15.4% |
| 2011 Q1 | 570.5 Million USD | 0.41% |
| 2011 FY | 2.53 Billion USD | 14.26% |
| 2011 Q4 | 738.01 Million USD | 19.08% |
| 2011 Q3 | 619.75 Million USD | 1.69% |
| 2011 Q2 | 609.44 Million USD | 6.83% |
| 2010 Q2 | 565.08 Million USD | 3.51% |
| 2010 Q3 | 541.81 Million USD | -4.12% |
| 2010 Q4 | 568.16 Million USD | 4.86% |
| 2010 FY | 2.22 Billion USD | 2.83% |
| 2010 Q1 | 545.94 Million USD | -4.0% |
| 2009 Q4 | 568.71 Million USD | -44.5% |
| 2009 FY | 2.15 Billion USD | -1.54% |
| 2009 Q3 | 1.02 Billion USD | -3.8% |
| 2009 Q1 | 506.94 Million USD | -0.23% |
| 2009 Q2 | 1.06 Billion USD | 110.11% |
| 2008 Q4 | 508.14 Million USD | -4.12% |
| 2008 Q2 | 594.84 Million USD | 6.07% |
| 2008 Q1 | 560.78 Million USD | 3.56% |
| 2008 FY | 2.19 Billion USD | 9.15% |
| 2008 Q3 | 529.95 Million USD | -10.91% |
| 2007 Q4 | 541.5 Million USD | 10.94% |
| 2007 Q1 | 472.86 Million USD | 0.33% |
| 2007 FY | 2 Billion USD | 11.01% |
| 2007 Q2 | 507.36 Million USD | 7.3% |
| 2007 Q3 | 488.1 Million USD | -3.8% |
| 2006 FY | 1.81 Billion USD | 5.56% |
| 2006 Q4 | 471.33 Million USD | 8.17% |
| 2006 Q3 | 435.72 Million USD | -7.77% |
| 2006 Q2 | 472.44 Million USD | 9.62% |
| 2006 Q1 | 430.99 Million USD | -3.66% |
| 2005 Q2 | 444.83 Million USD | 9.3% |
| 2005 Q3 | 415.96 Million USD | -6.49% |
| 2005 Q4 | 447.36 Million USD | 7.55% |
| 2005 Q1 | 406.97 Million USD | -12.09% |
| 2005 FY | 1.71 Billion USD | 1.23% |
| 2004 Q1 | 415.38 Million USD | 16.56% |
| 2004 Q4 | 462.93 Million USD | 18.52% |
| 2004 Q3 | 390.59 Million USD | -8.17% |
| 2004 Q2 | 425.32 Million USD | 2.39% |
| 2004 FY | 1.69 Billion USD | 7.85% |
| 2003 Q1 | 396.18 Million USD | -5.91% |
| 2003 Q4 | 356.36 Million USD | -11.0% |
| 2003 Q3 | 400.42 Million USD | -4.19% |
| 2003 Q2 | 417.94 Million USD | 5.49% |
| 2003 FY | 1.57 Billion USD | 3.78% |
| 2002 FY | 1.51 Billion USD | 34.07% |
| 2002 Q3 | 363.45 Million USD | -3.84% |
| 2002 Q4 | 421.09 Million USD | 15.86% |
| 2002 Q1 | 351.21 Million USD | -6.41% |
| 2002 Q2 | 377.97 Million USD | 7.62% |
| 2001 Q3 | 253.5 Million USD | -0.45% |
| 2001 Q4 | 375.28 Million USD | 48.04% |
| 2001 Q1 | 245.66 Million USD | 2.91% |
| 2001 Q2 | 254.63 Million USD | 3.65% |
| 2001 FY | 1.12 Billion USD | 26.89% |
| 2000 Q4 | 238.72 Million USD | 10.9% |
| 2000 Q3 | 215.25 Million USD | -3.6% |
| 2000 Q2 | 223.29 Million USD | 5.06% |
| 2000 Q1 | 212.53 Million USD | -4.09% |
| 2000 FY | 889.79 Million USD | 7.09% |
| 1999 Q3 | 203.6 Million USD | -2.63% |
| 1999 FY | 830.9 Million USD | 4.5% |
| 1999 Q1 | 196.6 Million USD | -10.76% |
| 1999 Q2 | 209.1 Million USD | 6.36% |
| 1999 Q4 | 221.6 Million USD | 8.84% |
| 1998 Q3 | 197 Million USD | -0.05% |
| 1998 Q4 | 220.3 Million USD | 11.83% |
| 1998 FY | 795.1 Million USD | 10.31% |
| 1998 Q1 | 180.7 Million USD | -8.51% |
| 1998 Q2 | 197.1 Million USD | 9.08% |
| 1997 Q2 | 178.3 Million USD | 3.42% |
| 1997 FY | 720.8 Million USD | 9.78% |
| 1997 Q4 | 197.5 Million USD | 14.36% |
| 1997 Q3 | 172.7 Million USD | -3.14% |
| 1997 Q1 | 172.4 Million USD | -4.38% |
| 1996 Q2 | 165 Million USD | 5.84% |
| 1996 FY | 656.6 Million USD | 14.79% |
| 1996 Q4 | 180.3 Million USD | 16.1% |
| 1996 Q3 | 155.3 Million USD | -5.88% |
| 1996 Q1 | 155.9 Million USD | -3.59% |
| 1995 FY | 572 Million USD | 8.99% |
| 1995 Q4 | 161.7 Million USD | 17.77% |
| 1995 Q3 | 137.3 Million USD | -1.86% |
| 1995 Q2 | 139.9 Million USD | 5.11% |
| 1995 Q1 | 133.1 Million USD | -5.0% |
| 1994 FY | 524.8 Million USD | -5.03% |
| 1994 Q1 | 140.4 Million USD | -5.01% |
| 1994 Q2 | 141.1 Million USD | 0.5% |
| 1994 Q3 | 129.9 Million USD | -7.94% |
| 1994 Q4 | 140.1 Million USD | 7.85% |
| 1993 FY | 552.6 Million USD | 553.19% |
| 1993 Q4 | 147.8 Million USD | 10.71% |
| 1993 Q3 | 133.5 Million USD | 1.29% |
| 1993 Q2 | 131.8 Million USD | 196.18% |
| 1993 Q1 | 44.5 Million USD | 0.91% |
| 1992 Q2 | 28.9 Million USD | 22.98% |
| 1992 FY | 84.6 Million USD | 55.23% |
| 1992 Q3 | 38.7 Million USD | 33.91% |
| 1992 Q4 | 44.1 Million USD | 13.95% |
| 1992 Q1 | 23.5 Million USD | 9.81% |
| 1991 Q2 | 19.2 Million USD | 3.78% |
| 1991 Q3 | 20.5 Million USD | 6.77% |
| 1991 FY | 54.5 Million USD | 85.37% |
| 1991 Q1 | 18.5 Million USD | 5.11% |
| 1991 Q4 | 21.4 Million USD | 4.39% |
| 1990 Q4 | 17.6 Million USD | 64.49% |
| 1990 FY | 29.4 Million USD | 58.06% |
| 1990 Q3 | 10.7 Million USD | 37.18% |
| 1990 Q2 | 7.8 Million USD | -1.27% |
| 1990 Q1 | 7.9 Million USD | 12.86% |
| 1989 Q4 | 7 Million USD | -4.11% |
| 1989 Q1 | 4.6 Million USD | -6.12% |
| 1989 Q3 | 7.3 Million USD | 0.0% |
| 1989 Q2 | 7.3 Million USD | 58.7% |
| 1989 FY | 18.6 Million USD | 14.81% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | -4003.153% |
| AngioDynamics, Inc. | 303.91 Million USD | -1204.645% |
| AtriCure, Inc. | 399.24 Million USD | -893.125% |
| Avinger, Inc. | 7.65 Million USD | -51716.519% |
| Azenta, Inc. | 665.07 Million USD | -496.176% |
| BioLife Solutions, Inc. | 143.27 Million USD | -2667.483% |
| The Cooper Companies, Inc. | 3.59 Billion USD | -10.347% |
| Daxor Corporation | 1.28 Million USD | -309541.043% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -21591.559% |
| Femasys Inc. | 1.07 Million USD | -369779.754% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | -3432.294% |
| Hologic, Inc. | 4.03 Billion USD | 1.62% |
| ICU Medical, Inc. | 2.25 Billion USD | -75.51% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 44.344% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -13803.662% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | -1949.265% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -343940.976% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -343940.976% |
| Masimo Corporation | 2.04 Billion USD | -93.594% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | -3983.465% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | -215.342% |
| Nephros, Inc. | 14.23 Million USD | -27748.012% |
| NovoCure Limited | 509.33 Million USD | -678.461% |
| NEXGEL, Inc. | 4.08 Million USD | -96867.474% |
| NEXGEL, Inc. | 4.08 Million USD | -96867.474% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -136107.489% |
| OraSure Technologies, Inc. | 405.47 Million USD | -877.873% |
| Pro-Dex, Inc. | 53.84 Million USD | -7263.866% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -222641.171% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -20654.436% |
| QuidelOrtho Corporation | 2.99 Billion USD | -32.264% |
| Repligen Corporation | 638.76 Million USD | -520.73% |
| Sanara MedTech Inc. | 64.98 Million USD | -6000.954% |
| STAAR Surgical Company | 322.41 Million USD | -1129.781% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -7794.632% |
| Jin Medical International Ltd. | 19.82 Million USD | -19903.575% |